FDA NDC Directory · JSON-LD · Markdown

TECARTUS

NDC 71287-219 · CELLULAR THERAPY · SUSPENSION

Generic namebrexucabtagene autoleucel
Labeler / ManufacturerKite Pharma, Inc.
Marketing categoryBiologic License Application · App BLA125703
Dosage form / routeSUSPENSION · INTRAVENOUS
Active ingredientsBREXUCABTAGENE AUTOLEUCEL (2000000 1/68mL)
Marketing started20200724
Package count1

External sources

Source: openFDA. Public-domain (CC0).